PRESS RELEASE published on 06/19/2023 at 14:30, 3 years 2 months ago invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
PRESS RELEASE published on 04/18/2023 at 15:00, 3 years 4 months ago invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023
Published on 08/19/2026 at 16:00, 50 minutes ago Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Published on 08/19/2026 at 15:55, 55 minutes ago Drill Permit Received for Storm Exploration's Gold Standard Project
Published on 08/19/2026 at 14:40, 2 hours 10 minutes ago Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Published on 08/19/2026 at 13:00, 3 hours 50 minutes ago UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Published on 08/19/2026 at 13:00, 3 hours 50 minutes ago Abasca Announces Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit: After-Tax NPV of US$130 Million and 16.7% IRR
Published on 08/19/2026 at 16:15, 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/19/2026 at 16:14, 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/18/2026 at 11:15, 1 day 5 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 21 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 2 days 8 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 2 days 9 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026
